Recent applications of ultrasound: Diagnosis and treatment of hepatocellular carcinoma

International Journal of Clinical Oncology

Volumn 11, Issue 4, 2006, Pages 258-267

  Maruyama, Hitoshi ^a   Ebara, Masaaki ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast agent; HCC; Liver; Microbubble; Three dimensional image; Ultrasound (US)

Indexed keywords

'BIOSPHERE'; AL 700; ALBUNEX; ECHO CONTRAST MEDIUM; ECHOVIST; FLUOROCARBON; FS 069; IODINATED CONTRAST MEDIUM; NC 100100; OCTAFLUOROPROPANE; PERFLEXANE; PERFLUOROPENTANE; PERFLUTREN; QUANTISON; SHU 508; SONAVIST; SONOVUE; UNCLASSIFIED DRUG;

BLOOD RHEOLOGY; CANCER DIAGNOSIS; CHEMOEMBOLIZATION; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; HEMODYNAMICS; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER NODULE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; SENSITIVITY AND SPECIFICITY; THREE DIMENSIONAL IMAGING; TUMOR VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; SURGERY, COMPUTER-ASSISTED; ULTRASONIC THERAPY; ULTRASONICS; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 33748111454     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-006-0585-2     Document Type: Review

References (136)

1. FW Kremkau 1993 Diagnostic ultrasound: principles and instruments 4th edn WB Saunders Philadelphia
2. FW Kremkau 1995 Doppler ultrasound: principles and instruments 2nd edn WB Saunders Philadelphia
3. BB Goldberg 1997 Ultrasound contrast agents Martin Dunitz London
4. TR Nelson DH Pertorius 1998 Three-dimensional ultrasound imaging Ultrasound Med Biol 24 1243 1270
5. DB Downey A Fenster JC Williams 2000 Clinical utility of three-dimensional US Radiographics 20 559 571
6. M Ohto E Karasawa Y Tsuchiya 1980 Ultrasonically guided percutaneous contrast medium injection and aspiration biopsy using a real-time puncture transducer Radiology 136 171 176
7. JC Sheu GT Huang DS Chen 1987 Small hepatocellular carcinoma: intratumor ethanol treatment using new needle and guidance systems Radiology 163 43 48
8. CA Linke EL Carstensen LA Fizzell 1973 Localized tissue destruction by high-intensity focused ultrasound Arch Surg 107 887 891
9. CR Hill GR ter Haar 1995 High-intensity ultrasound-potential for cancer treatment Br J Radiol 68 1296 1303
10. K Tachibana S Tachibana 2001 The use of ultrasound for drug delivery Echocardiography 18 323 347
11. CJ Harvey T Albrecht 2001 Ultrasound of focal lesions Eur Radiol 11 1578 1593
12. RS Shapiro J Wagreich RB Parsons 1998 Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography AJR Am J Roentgenol 171 1203 1206
13. LE Hann AM Bach LD Cramer 1999 Hepatic sonography: comparison between tissue harmonic and standard sonography techniques AJR Am J Roentgenol 173 201 206
14. TA Whittingham 1999 Tissue harmonic imaging Eur Radiol 9 S323 S326
15. PNT Wells M Halliwell R Skidmore 1977 Tumor detection by ultrasonic Doppler blood-flow signals Ultrasonics 15 231 236
16. CRB Merritt 1987 Doppler color flow imaging J Clin Ultrasound 15 591 597
17. EG Grant FN Tessler RR Perrella 1988 Clinical Doppler imaging AJR Am J Roentgenol 152 707 717
18. KJW Taylor I Ramos SS Morse 1987 Focal liver masses: differential diagnosis with pulsed Doppler US Radiology 164 643 647
19. KJW Taylor I Ramos D Carter 1988 Correlation of Doppler US tumor signals with neovascular morphologic features Radiology 166 57 62
20. DG Mitchell 1990 Color Doppler imaging: principles, limitations, and artifacts Radiology 177 1 10
21. S Tanaka T Kitamura M Fujita 1990 Color Doppler flow imaging of liver tumors AJR Am J Roentgenol 154 509 514
22. WD Foley SJ Erickson 1991 Color Doppler flow imaging AJR Am J Roentgenol 156 3 13
23. M Nino-Murcia PW Ralls RB Jeffrey Jr 1992 Color flow Doppler characterization of focal hepatic lesions AJR Am J Roentgenol 159 1195 1197
24. JM Rubin RO Bude PL Carson 1994 Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler sonography Radiology 190 853 856
25. BI Choi TK Kim JK Han 1996 Power versus conventional color Doppler sonography: comparison in the depiction of vasculature in liver tumors Radiology 200 55 58
26. R Lencioni F Pinto N Armillotta 1996 Assessment of tumor vascularity in hepatocellular carcinoma: comparison of power Doppler US and color Doppler US Radiology 201 353 358
27. S Gaiani L Volpe F Piscaglia 2001 Vascularity of liver tumours and recent advances in Doppler ultrasound J Hepatol 34 474 482
28. R Gramiak PM Shah 1968 Echocardiography of the aortic root Invest Radiol 3 356 366
29. MC Ziskin A Bonakdapour DP Weinstein 1972 Contrast agents for diagnostic ultrasound Invest Radiol 7 500 505
30. BB Goldberg 1976 Ultrasonic cholangiography Radiology 118 401 404
31. RS Mertzer V Klig LE Teichholz 1985 Gererating precision microbubbles for use as an echocardiographic contrast agent J Am Coll Cardiol 5 978 982
32. MR Violante HW Fischer JA Mahoney 1980 Particulate contrast media Invest Radiol 15 S329 334
33. RF Mattrey FW Scheible BB Gosink 1982 Perfluorooctyl bromide: a liver-spleen specific and tumor-imaging ultrasound contrast material Radiology 145 759 762
34. RF Mattrey GR Leopold E von Sonnenberg 1983 Perfluorochemicals as liver and spleen-seeking ultrasound contrast agents J Ultrasound Med 2 173 176
35. KJ Parker TA Tuthill RM Lerner 1987 A particulate contrast agent with potential for ultrasound imaging of liver Ultrasound Med Biol 13 555 566
36. IJ Fink DL Miller TH Shawker 1985 Lipid emulsions as contrast agents for hepatic sonography: an experimental study in rabbits Ultrason Imaging 7 191 197
37. M Kudo S Tomita H Tochio 1992 Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles Radiology 182 155 160
38. Y Matsuda I Yabuuchi 1986 Hepatic tumors: US contrast enhancement with CO2 microbubbles Radiology 161 701 705
39. Goldberg BB, Liu JB, Forsberg F (1994) Ultrasound contrast agents: a review. Ultrasound Med Biol 319-333
40. R Schlief 1996 Development of echo-enhancing agents Clin Radiol 51 S5 S7
41. MJ Blomley T Albrecht DO Cosgrove 1998 Stimulated acoustic emission in liver parenchyma with Levovist Lancet 351 568
42. M Schneider 1999 SonoVue, a new ultrasound contrast agent Eur Radiol 9 S347 S348
43. A Bauer M Blomley E Leen 1999 Liver-specific imaging with SHU 563A: diagnostic potential of a new class of ultrasound contrast media Eur Radiol 9 S349 S352
44. C Marelli 1999 Preliminary experience with NC100100, a new ultrasound contrast agent for intravenous injection Eur Radiol 9 S343 346
45. DR Morel I Schwieger L Hohn 2000 Human pharmacokinetics and safety evaluation of SonoVue™, a new contrast agent for ultrasound imaging Invest Radiol 35 80 85
46. H Maruyama S Matsutani H Saisho 2004 Different behaviors of microbubbles in the liver: time-related quantitative analysis of two ultrasound contrast agents, Levovist and Definity Ultrasound Med Biol 30 1035 1040
47. AK Lim N Patel RJ Eckersley 2004 Evidence for spleen-specific uptake of a microbubble contrast agent: a quantitative study in healthy volunteers Radiology 231 785 788
48. J Ophir KJ Parker 1989 Contrast agents in diagnostic ultrasound Ultrasound Med Biol 15 319 333
49. PN Burns 1996 Harmonic imaging with ultrasound contrast agents Clin Radiol 51 Suppl 1 50 55
50. PN Burns SR Wilson DH Simpson 2000 Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast Invest Radiol 35 58 71
51. P Hauff T Fritzsch M Reinhardt 1997 Delineation of experimental liver tumors in rabbits by a new ultrasound contrast agent and stimulated acoustic emission Invest Radiol 32 94 99
52. A Bauer R Schlief M Zomack 1997 Acoustically stimulated microbubbles in diagnostic ultrasound: properties and implications for diagnostic use NC Nanda R Schlief BB Golgberg Advances in echo imaging using contrast enhancement 2nd ed Kluwer Academic Lancaster 669 690
53. N Kamiyama F Moriyasu Y Mine 1998 Analysis of flash echo from contrast agent for designing optimal ultrasound diagnostic systems Ultrasound Med Biol 25 411 420s
54. H Maruyama S Matsutani H Saisho 2000 Grey-scale contrast-enhancement in rabbit liver with DMP115 at different acoustic power levels Ultrasound Med Biol 26 1429 1438
55. A Bauer L Solbiati N Weissman 2002 Ultrasound imaging with SonoVue: low mechanical index real-time imaging Acad Radiol 9 Suppl 2 S282 284
56. H Maruyama S Matsutani H Saisho 2003 Extra-low acoustic power harmonic images of the liver with perflutren: novel imaging for real-time observation of liver perfusion J Ultrasound Med 22 931 938
57. T Albrecht A Oldenburg J Hohmann 2003 Imaging of liver metastases with contrast-specific low-MI real-time ultrasound and SonoVue Eur Radiol 13 Suppl 3 N79 N86
58. C Greis 2004 Technology overview: SonoVue (Bracco, Milan) Eur Radiol 14 S11 S15
59. K Numata K Tanaka T Kiba 2001 Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma. Correlation with helical computed tomographic findings J Ultrasound Med 20 89 98
60. A Giorgio G Ferraioli L Tarantino 2004 Contrast-enhanced sonographic appearance of hepatocellular carcinoma in patients with cirrhosis: comparison with contrast-enhanced helical CT appearance AJR Am J Roentgenol 183 1319 1326
61. L Bolondi S Gaiani N Celli 2005 Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma Hepatology 42 27 34
62. TK Kim BI Choi JK Han 2000 Hepatic tumors: contrast agent-enhancement patterns with pulse-inversion harmonic US Radiology 216 411 417
63. A von Herbay C Vogt D Haussinger 2002 Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions J Ultrasound Med 21 1191 1200
64. J Furuse M Nagase H Ishii 2003 Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions Br J Radiol 76 385 392
65. A von Herbay C Vogt D Haussinger 2002 Late-phase pulse-inversion sonography using the contrast agent Levovist: differentiation between benign and malignant focal lesions of the liver AJR Am J Roentgenol 179 1273 1279
66. A von Herbay C Vogt D Haussinger 2004 Differentiation between benign and malignant hepatic lesions: utility of color stimulated acoustic emission with the microbubble contrast agent J Ultrasound Med 23 207 215
67. TH Bryant MJ Blomley T Albrecht 2004 Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study Radiology 232 799 809
68. CF Dietrich A Ignee J Trojan 2004 Improved characterization of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A Gut 53 401 405
69. A von Herbay C Vogt R Willers 2004 Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions J Ultrasound Med 23 1557 1568
70. C Nicolau R Vilana V Catala 2006 Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions AJR Am J Roentgenol 186 158 167
71. SH Kim JM Lee JY Lee 2005 Value of contrast-enhanced sonography for the characterization of focal hepatic lesions in patients with diffuse liver disease: Receiver operating characteristic analysis AJR Am J Roentgenol 184 1077 1084
72. C Nicolau V Catala R Vilana 2004 Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation Eur Radiol 14 1092 1099
73. M Kudo 1999 Imaging diagnosis of hepatocellular carcinoma and premalignant/borderline lesions Semin Liver Dis 19 297 309
74. M Hayashi O Matsui K Ueda 2002 Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material Radiology 225 143 149
75. M Roncalli E Roz G Coggi 1999 The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implication for diagnosis and classification Hepatology 30 1174 1178
76. International Working Party 1995 Terminology of nodular hepatocellular lesions Hepatology 22 983 989
77. M Borzio S Fargion F Borzio 2003 Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development J Hepatol 39 208 214
78. MJ Blomley T Albrecht DO Cosgrove 1999 Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SHU 508A: early experience Radiology 210 409 416
79. CJ Harvey MJ Blomley RJ Eckersley 2000 Pulse-inversion mode imaging of liver specific microbubbles: improved detection of subcentimetre metastases Lancet 355 807 808
80. CJ Harvey MJ Blomley RJ Eckersley 2000 Hepatic malignancies: improved detection with pulse-inversion US in late phase of enhancement with SHU 508A-early experience Radiology 216 903 908
81. TK Kim BI Choi HS Hong 2000 Improved imaging of hepatic metastases with delayed pulse inversion harmonic imaging using a contrast agent SHU 508A: preliminary study Ultrasound Med Biol 26 1439 1444
82. F Forsberg CW Piccoli JB Liu 2002 Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase Radiology 222 824 829
83. M Krix F Kiessling M Essig 2004 Low mechanical index contrast-enhanced ultrasound better reflects high arterial perfusion of liver metastases than arterial phase computed tomography Invest Radiol 39 216 222
84. H Maruyama S Matsutani H Saisho 2005 Real-time blood-pool images of contrast enhanced ultrasound with Definity in the detection of liver tumour nodules in the liver Br J Radiol 78 512 518
85. MJ Blomley T Albrecht DO Cosgrove 1998 Liver vascular transit time analyzed with dynamic hepatic venography with bolus injections of a US contrast agent: Early experience in seven patients with metastases Radiology 209 862 866
86. T Albrecht MJ Blomley DO Cosgrove 1999 Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent Lancet 354 598 599
87. T Albrecht A Urbank M Mahler 1998 Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: preliminary experience Radiology 207 339 347
88. JM Correas PN Burns X Lai 2000 Infusion versus bolus of an ultrasound contrast agent Invest Radiol 35 72 79
89. EK Fishman D Magid DR Ney 1991 Three-dimensional imaging Radiology 181 321 337
90. RN Rankin A Fenster DB Downey 1993 Three-dimensional sonographic reconstruction: techniques and diagnostic applications AJR Am J Roentgenol 161 695 702
91. PA Picot DW Rickey R Mitchell 1993 Three-dimensional colour Doppler imaging Ultrasound Med Biol 19 95 104
92. UM Hamper V Trapanotto S Sheth 1994 Three-dimensional US: preliminary clinical experience Radiology 191 397 401
93. DB Downey A Fenster 1995 Vascular imaging with a three-dimensional power Doppler system AJR Am J Roentgenol 165 665 668
94. CJ Ritchie WS Edwards LA Mack 1996 Three-dimensional ultrasonic angiography using power-mode Doppler Ultrasound Med Biol 22 277 286
95. M Ohto H Kato H Tsujii 2005 Vascular flow patterns of hepatic tumors in contrast-enhanced three-dimensional fusion ultrasonography using plane shift and opacity control modes J Ultrasound Med 24 49 57
96. P Acar Y Dulac A Taktak 2005 Real-time three-dimensional fetal echocardiography using matrix probe Prenat Diagn 25 370 375
97. PP Sengupta K Chandrasekaran DJ Prince 2005 Role of biplane echocardiography in a large-volume clinical practice: revamping strategies for echocardiography in a limited time J Am Soc Echocardiogr 18 757 760
98. MJ Monaghan 2006 Role of real time 3D echocardiography in evaluating the left ventricle Heart 92 131 136
99. K Okuda 1992 Hepatocellular carcinoma: recent progress Hepatology 15 948 963
100. K Okuda 2000 Hepatocellular carcinoma J Hepatol 32 S225 S237
101. J Bruix M Sherman J Llovet EASL Panel of Experts on HCC 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference J Hepatol 35 421 430
102. M Ebara M Ohto N Sugiura 1990 Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients J Gastroenterol Hepatol 5 616 626
103. S Shiina K Tagawa T Unuma 1990 Percutaneous ethanol injection therapy for the treatment of hepatocellular carcinoma AJR Am J Roentgenol 154 947 951
104. T Livraghi L Bolondi S Lazzaroni 1992 Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients Cancer 69 925 929
105. RD Redvanly JL Chezmar RM Strauss 1993 Malignant hepatic tumors: Safety of high-dose percutaneous ethanol ablation therapy Radiology 188 283 285
106. SN Goldberg GS Gazelle L Solbiati 1996 Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode Acad Radiol 3 636 644
107. L Solbiati SN Goldberg T Ierace 1997 Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes Radiology 205 367 373
108. R Lencioni C Bartolozzi D Caramella 1995 Treatment of small hepatocellular carcinoma with percutaneous ethanol injection: analysis of prognostic factors in 105 Western patients Cancer 76 1737 1746
109. M Ryu Y Shimamura T Kinoshita 1997 Therapeutic results of resection, transcatheter arterial embolization and percutaneous ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study Jpn J Clin Oncol 27 251 257
110. M Ebara S Okabe K Kita 2005 Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation J Hepatol 43 458 464
111. T Livraghi SN Goldberg S Lazzaroni 1999 Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection Radiology 210 655 661
112. T Livraghi S Lazzaroni F Meloni 2001 Radiofrequency thermal ablation of hepatocellular carcinoma Eur J Ultrasound 13 159 166
113. RA Lencioni HP Allgaier D Cioni 2003 Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection Radiology 228 235 240
114. A Giorgio L Tarantino G Stefano 2003 Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma AJR Am J Roentgenol 181 479 484
115. E Caturelli L Solmi M Anti 2004 Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study Gut 53 1356 1362
116. E Caturelli E Biasini F Bartolucci 2002 Diagnosis of hepatocellular carcinoma complicating liver cirrhosis: utility of repeat ultrasound-guided biopsy after unsuccessful first sampling Cardiovasc Intervent Radiol 25 295 299
117. RH Gottlieb WB Robinette DJ Rubens 1998 Coating agent permits improved visualization of biopsy needles during sonography AJR Am J Roentgenol 171 1301 1302
118. WC Culp TC [tmp] McCowan TC Goertzen 2000 Relative ultrasonographic echogenicity of standard, dimpled and polymeric-coated needles J Vasc Interv Radiol 11 351 358
119. D Bergin JN Pappas JJ Hwang 2002 Echogenic polymer coating: does it improve needle visualization in sonographically guided biopsy? AJR Am J Roentgenol 178 1188 1190
120. C Bartolozzi R Lencioni P Ricci 1998 Hepatocellular carcinoma treatment with percutaneous ethanol injection: Evaluation with contrast-enhanced color Doppler US Radiology 209 387 393
121. L Solbiati SN Goldberg T Ierace 1999 Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent-early experience Radiology 211 643 649
122. D Choi HK Lim SH Kim 2000 Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results Radiology 217 558 563
123. YL Wen M Kudo RQ Zheng 2003 Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography AJR Am J Roentgenol 181 57 63
124. CK Kim D Choi HK Lim 2005 Therapeutic response assessment of percutaneous radio frequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging Eur J Radiol 56 66 73
125. MF Meloni SN Goldberg T Livraghi 2001 Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT AJR Am J Roentgenol 177 375 380
126. Y Minami M Kudo T Kawasaki 2003 Chemoembolization of hepatocellular carcinoma: usefulness of coded phase-inversion harmonic sonography AJR Am J Roentgenol 180 703 708
127. M Morimoto K Shirato K Sugimori 2003 Contrast-enhanced harmonic gray-scale sonographic-histologic correlation of the therapeutic effects of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma AJR Am J Roentgenol 181 65 69
128. M Pompili L Riccardi M Covino 2005 Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma Liver Int 25 954 961
129. JE Kennedy GR Haar D Cranston 2003 High intensity focused ultrasound: surgery of the future? Br J Radiol 76 590 599
130. JE Kennedy F Wu GR Haar 2004 High-intensity focused ultrasound for the treatment of liver tumours Ultrasonics 42 931 935
131. CX Li GL Xu ZY Jiang 2004 Analysis of clinical effect of high-intensity focused ultrasound on liver cancer World J Gastroenterol 10 2201 2204
132. F Wu Z Wang W Chen 2005 Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization Radiology 235 659 667
133. DL Miller J Quddus 2000 Sonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodies Ultrasound Med Biol 26 661 667
134. CM Newman A Lawrie AF Brisken 2001 Ultrasound gene therapy: on the road from concept to reality Echocardiography 18 339 347
135. H Pan Y Zhou O Izadnegahdar 2005 Study of sonoporation dynamics affected by ultrasound duty cycle Ultrasound Med Biol 31 849 856
136. Y Sakakima S Hayashi Y Yagi 2005 Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents Cancer Gene Ther 12 884 889